期刊文献+

妇科恶性肿瘤患者绝经相关症状管理 被引量:8

下载PDF
导出
摘要 目前妇科恶性肿瘤发病率高,且日趋年轻化。妇科恶性肿瘤患者的治疗,必然造成卵巢功能的损害,机体雌激素水平降低,进而导致患者不可避免地出现绝经相关症状,严重影响患者的生活质量。妇科恶性肿瘤患者尤其是年轻患者的生存质量问题日益受到重视,采用激素补充治疗(HRT)其绝经相关症状成为越来越多患者的选择。但对于HRT应持慎重态度,与患者充分沟通,知情选择,根据患者的具体情况,权衡利弊、个体化地选择治疗药物,缓解绝经相关症状,提高生命质量。而非激素药物在妇科恶性肿瘤患者绝经相关症状的应用,也为临床提供了更多的治疗选择。
机构地区 成都军区总医院
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2014年第2期100-102,共3页 Journal of Practical Obstetrics and Gynecology
  • 相关文献

参考文献18

  • 1Jemal A,Bray F,Center MM. Global cancer statistics[J].Cancer J Clinicians,2011,(02):69-90.
  • 2张乃怿,吴成,廖秦平.子宫内膜癌的现状和筛查[J].中华临床医师杂志(电子版),2011,5(3):124-129. 被引量:77
  • 3郭科军,葛莉莉,薛晖.年轻妇女宫颈癌的发病趋势及临床病理特点[J].中国肿瘤临床,2007,34(5):269-270. 被引量:13
  • 4Pines A,Sturdee DW. IMS updated recommendations on postmenopausal hormone therapy[J].CLIMACTERIC,2007,(03):181-194.
  • 5绝经过渡期和绝经后期激素补充治疗临床应用指南(2009版)[J].中华妇产科杂志,2010,45(8):635-638. 被引量:136
  • 6Ayhan A,Taskiranc C,Simsek S. Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors[J].International Journal of Gynecological Cancer,2006,(02):805-808.
  • 7Arteaga-Gomez AC,Castellanos-Barroso G,Colin-Valenzuela A. Hormone therapy effect in postmenopausal women with history of endometrial cancer[J].Ginecol Obstet Met,2011,(01):11-17.
  • 8Suriano KA,Mc Hale M,Mc Laren CE. Estrogen replacement therapy in endometrial cancer patients:a matched control study[J].OBSTETRICS AND GYNECOLOGY,2001,(04):555-560.
  • 9Mueck AO,Seeger H. Hormone therapy after endometrial cancer[J].Hormone Research,2004,(01):40-48.
  • 10Schindler AE. Hormone replacement therapy(HRT) in women after genital cancer[J].MATURITAS,2002,(01):s105-s111.

二级参考文献46

  • 1赵健.子宫内膜细胞学诊断系统[J].中国生育健康杂志,2006,17(1):6-8. 被引量:64
  • 2Board of the International Menopause Society,Pines A,Sturdee DW,et al.IMS updated recommendations on postmenopausal hormone therapy.Climacteric,2007,10:181-194.
  • 3Gompel A,Rozenberg S,Barlow DH,et al.The EMAS 2008update on clinical recommendations on postmenopausal hormone replacement therapy.Maturitas,2008,61:227-232.
  • 4Utian WH,Archer DF,Bachmann GA,et al.Estrogen and progestogen use in postmenopausal women:July 2008 position statement of The North American Menopause Society.Menopause,2008,15:584-602.
  • 5North American Menopause Society.The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women:2007 position statement of The North American Menopause Society.Menopause,2007,14:355-369.
  • 6APMF 2008 Consensus Statement on the Management of the Menopause[DB/OL] .[2010-7-2] .http://www.apmf.net/news/.
  • 7Uebelhack R, Blohmer JU, Graubaum HJ, et al. Black cohosh and St. Johnrs wort for climacteric complaints: a ran domized trial[J]. Obstet Gyneeol, 2006, 107 (2 Pt 1): 247 255.
  • 8Osmers R, Friede M, Liske E. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms [J].Obstet Gynecol, 2005, 105 (5 Pt 1):1074- 1078.
  • 9Wuttke W, Seidlovd-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double- blind placebo-controlled study: effects on menopause symp toms and bonemarkers[J]. Maturitas, 2003,44 [Suppl 1]:67-77.
  • 10Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase Ⅲ double blind, randomized, placebo controlled crossover trial of black cohosh in the management of hot flashes[J]. J Clin Oncol, 2006, 24(18):2836- 2841.

共引文献231

同被引文献60

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部